Back to Peptides
CognitiveMedium Risk

Vasopressin

Also known as: ADH, Antidiuretic Hormone, Arginine Vasopressin, AVP

Half-life:
10-20 minutes

Administration Routes

intranasalsubcutaneous injectionintravenous
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Neuropeptide binding V1aR (social behavior/memory, vasoconstriction), V1bR (ACTH/stress), V2R (antidiuretic); enhances hippocampal memory consolidation and social recognition

A neuropeptide with established effects on memory consolidation, particularly for social and declarative memory. Studied off-label for cognitive enhancement and social memory deficits.

Primary Research Areas

  • memory consolidation
  • social memory
  • fluid retention
  • vasoconstriction

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Consult a healthcare professional before use.

Regulatory Status

Prescription OnlyFDA Approved

FDA-approved vasopressin injection. Brand: Vasostrict (NDA 204485, Apr 2014). Indicated for vasodilatory shock. Also on FDA 503A Category 1 compounding list. Prescription only.

Effective: April 17, 2014View FDA source →

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find Vasopressin